A randomized trial at a Florida university tested whether a brief educational video could change college students’ knowledge, attitudes, and intentions around delta-8 THC. The video reliably increased factual knowledge across all participants, but it reduced use intentions in only one narrow subgroup and left perceptions of risk, benefit, and regulation entirely unchanged.

Delta-8 THC occupies a regulatory gray zone that makes it accessible to young adults across much of the United States, yet clinicians, educators, and public health officials have virtually no evidence base to guide prevention efforts. Products sold as delta-8 THC have been flagged by the FDA and Poison Control for inconsistent labeling, contamination with heavy metals, and unexpectedly high concentrations of psychoactive cannabinoids. This study is among the first randomized experiments to test any educational tool targeting delta-8 THC in a college population, making its findings directly relevant to the clinicians, campus health professionals, and policymakers who are grappling with this rapidly expanding exposure without established intervention strategies.

Delta-8 THC is a hemp-derived cannabinoid that became widely accessible after the 2018 Farm Bill legalized hemp containing less than 0.3% delta-9 THC. Although chemically similar to delta-9 THC, delta-8 is commonly perceived as a milder, legal alternative, and the commercial market has expanded rapidly despite limited regulation and scarce safety data. This two-phase study at the University of Tampa first surveyed 291 college students about their delta-8 THC perceptions and motives (Phase 1, October through December 2022), then used those findings to develop a brief educational video that was tested against a control video in a randomized experiment with 120 students (Phase 2, March through April 2023). The theoretical rationale drew on the Health Belief Model and motivational frameworks, aiming to increase knowledge and shift risk-related attitudes.

Phase 1 revealed that 35% of students had tried delta-8 THC, with enhancement (pursuit of fun and positive affect) as the dominant motive. Conformity was the weakest motive, suggesting peer pressure plays a relatively minor role. Seventy-two percent of prior users perceived delta-8 as less intense than delta-9 THC, and most reported inhalation as the primary route. In the Phase 2 experiment, the educational video significantly increased delta-8 THC knowledge across all participants compared to control. However, intentions to use were reduced only among participants with prior but not recent use (more than 30 days ago); current users and never-users showed no significant change. Perceived benefits, perceived costs, and attitudes toward regulation were entirely unaffected. The study had no behavioral follow-up, and the authors acknowledge that larger, multi-site trials with longitudinal assessment are needed.

Teaching Facts About Delta-8 THC Is Easier Than Changing Minds: A Randomized Study

If you could teach every college student in America one true thing about delta-8 THC in ninety seconds, you’d expect that to matter. A new study suggests it does, but perhaps not in the way you’d hope, and not for the students who need it most. This two-phase experiment from the University of Tampa genuinely deserves credit for something rarely attempted: it surveyed students about what they actually believe about delta-8 THC, discovered that enjoyment and positive mood enhancement (not peer pressure) drive use, and then built a tailored educational video designed to address those specific misperceptions. That kind of needs-assessment-to-intervention pipeline is textbook good practice, and it fills a real gap in a field where delta-8 THC intervention research is virtually nonexistent. What the study found about knowledge transfer is clean and encouraging: students who watched the educational video knew more about delta-8 THC immediately afterward than those who watched a control video. But knowledge and behavior are different cognitive tasks. Knowing that sugar causes cavities doesn’t stop most people from eating dessert. And here, the pattern holds: perceived benefits, perceived costs, and attitudes toward regulation did not budge.

The most headline-worthy finding, that the video reduced use intentions in one subgroup, requires careful parsing. The reduction appeared only among students with prior but not recent use, a category that was not pre-registered, raising the possibility that this is a post-hoc discovery rather than a confirmed effect. It is a bit like tossing a coin ten times, noticing it landed heads five times in a row on the third through seventh toss, and declaring you’ve found a pattern. The pattern may be genuine, but you’d need to test it prospectively to be confident. Even more concerning, current users of delta-8 THC, the group at highest immediate risk, showed no measurable response to the video. If the educational intervention reaches only those who have already stepped away from use, its real-world impact on the population that matters most remains an open question. Adding to the uncertainty, every outcome was measured immediately after viewing. It is like asking someone right after watching a documentary about sugar whether they plan to eat less candy, and then never checking what they actually bought at the grocery store. Without any follow-up, we simply cannot know whether these knowledge gains persisted, let alone whether they translated into changed behavior.

For my patients, I would say this: there is still a great deal we do not know about delta-8 THC’s long-term effects, product labeling is inconsistent, and what feels like a milder, safer alternative to marijuana may carry risks we cannot fully predict. For my clinical colleagues, I see this study as a useful proof of concept that confirms the limits of didactic approaches in isolation, particularly for active users who were not responsive. For policymakers, the finding that even a well-designed video did not shift attitudes toward regulation suggests that education alone will not substitute for regulatory action on product safety and age-restricted access. In substance use prevention research, the gap between what an intervention teaches and what it changes in real-world behavior is almost always wider than it appears in immediate post-test data, and any intervention that does not reach active users has already missed its most important audience.

This study sits at the earliest stage of the intervention research arc for delta-8 THC. It establishes feasibility and provides a randomized proof-of-concept test, but it does not yet offer the level of evidence needed to guide scaled implementation. Its Phase 1 perceptions data are arguably more immediately useful to clinicians than the intervention results: knowing that enhancement motives dominate and that most users perceive delta-8 THC as weaker and shorter-lasting than delta-9 THC provides a concrete framework for patient conversations. Standard peer-pressure-resistance messaging appears poorly matched to this population’s actual decision-making, and clinicians should consider directly addressing the appeal of positive experiential effects when counseling young adults.

From a pharmacological standpoint, the finding that 86% of users reported inhalation as their primary consumption route raises respiratory safety concerns that should be discussed with patients, particularly given the documented presence of contaminants in some delta-8 THC products, including heavy metals and residual solvents from chemical conversion processes. The fact that delta-8 THC was unregulated in Florida at the time of this study is an important caveat; evolving state regulations may alter both access patterns and the relevance of these findings. One actionable recommendation: when screening young adult patients for substance use, explicitly ask about delta-8 THC by name, as many users do not consider it “marijuana” and may not disclose use when asked about cannabis in general terms.

This is a two-phase hybrid study comprising an exploratory cross-sectional survey and a small randomized controlled experiment, explicitly framed by the authors as a “Notes from the Field” preliminary report. It sits above observational and descriptive studies in the evidence hierarchy due to its randomized experimental component, but well below large confirmatory trials. The most important inference constraint is that all outcomes were measured immediately post-viewing with no behavioral follow-up, which means the study can support claims about immediate knowledge transmission but not about durable attitude change, behavioral modification, or real-world use reduction.

This study extends the descriptive work of Kruger and Kruger (2023), who documented consumer perceptions that delta-8 THC is milder and has fewer side effects than delta-9 THC, by confirming similar perceptions in a college sample and then attempting an intervention. The knowledge-gain finding is consistent with decades of health communication research showing that brief informational formats effectively transmit facts. However, the limited attitudinal and behavioral impact mirrors well-established findings from alcohol and tobacco prevention research, where knowledge-only interventions have historically underperformed motivational and skills-based approaches. The FDA’s 2021 consumer advisory on delta-8 THC highlighted many of the same safety concerns this video addressed, but this study provides the first experimental data on whether such messaging actually moves the needle in young adults.

The most consequential analytic choice was the post-hoc moderation analysis by use-history subgroup, which produced the study’s most noteworthy finding: reduced intentions among prior but not recent users. Without pre-registration, it is impossible to know how many subgroup splits were examined before this one was reported, raising the risk of a spurious finding. Had the researchers pre-specified this moderation or applied a Bonferroni correction across all tested subgroups, the statistical significance might not have survived. Additionally, an intent-to-treat analysis with follow-up at even two weeks would have substantially clarified whether the immediate knowledge gains had any staying power, potentially yielding either a more convincing or a clearly null result depending on durability.

The most likely overinterpretation is that this study demonstrates brief educational videos are effective for reducing delta-8 THC use among college students. In fact, use intentions were reduced in only one subgroup (prior but not recent users), and there was no measurement of actual use behavior at any time point. Current users, the population of greatest clinical concern, showed no measurable response. Equally important, the absence of change in perceived costs does not mean the video “failed.” It means the intervention’s reach was limited to factual knowledge and did not extend to deeper attitudinal restructuring, a distinction that should guide future development rather than be read as a verdict on the format itself. Finally, these results are drawn from a single Florida university with a demographically narrow sample and should not be generalized to all college students or all regulatory environments.

This study contributes genuinely useful early-stage evidence that a brief, tailored educational video can immediately increase college students’ factual knowledge about delta-8 THC. It does not establish durable behavior change, actual use reduction, or broad attitudinal shifts. The moderated intention finding, limited to prior but not recent users, should be treated as hypothesis-generating until replicated in a pre-registered, multi-site trial with behavioral follow-up. For now, this work justifies continued investment in targeted delta-8 THC education while underscoring that information alone is unlikely to be sufficient.

What is delta-8 THC, and how is it different from regular marijuana?

Delta-8 THC is a cannabinoid that is chemically similar to delta-9 THC, the primary psychoactive compound in marijuana. It is typically derived from hemp through chemical conversion and became widely available after the 2018 Farm Bill legalized hemp. Many users perceive it as milder, but product quality is inconsistent, and it can still produce intoxication and adverse effects. It occupies a regulatory gray area that varies by state.

Did the educational video actually stop students from using delta-8 THC?

No. The video increased factual knowledge across all participants, but it only reduced stated intentions to use in one specific subgroup: students who had tried delta-8 THC before but had not used it recently. Students who were currently using delta-8 THC showed no change in their intentions, and the study did not track whether anyone actually changed their behavior after watching the video.

Should I be worried about delta-8 THC products?

There are legitimate safety concerns. The FDA has issued consumer advisories noting that delta-8 THC products are often manufactured using chemicals that may leave harmful residues, and some products have tested positive for heavy metals and higher-than-labeled THC concentrations. Because most delta-8 THC markets are poorly regulated, there is limited quality assurance. If you are using or considering these products, discussing them openly with your physician is important.

Does this study apply to all college students?

Not directly. The study was conducted at a single university in Florida with a sample that was predominantly White, female, and made up of first- and second-year students enrolled in psychology courses. The experiences and motivations of students at other institutions, from different demographic backgrounds, or in states with different cannabis regulations may differ significantly.

Have thoughts on this? Share it: